| Name | Title | Contact Details |
|---|---|---|
Ashley Mahoney |
Senior Manager, Sales Operations | Profile |
Amanda Mikus |
Senior Director, Sales Operations and BI | Profile |
Ira Duarte |
Chief Financial Officer | Profile |
Lynda Harris |
Senior Director of Human Resources | Profile |
Nancy Knochel Clodfelter |
Human Resources Director | Profile |
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.
Loyale is reinventing the way healthcare providers engage with their patients financially. With Loyale`s end-to-end suite of solutions, providers of all types and configurations are elevating their patients` financial experiences to a level that compares with their clinical experiences. With Loyale, providers build durable, trusting relationships with patients. They also increase revenues, reduce staff time & stress, and minimize bad debt.
MicroMRI is a Langhorne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rovin Med, is a Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The New York Genome Center (NYGC) is at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations are united in this unprecedented collaboration of technology, science, and medicine. We implement advanced genomic research, and integrate our findings with world-class technologies and physician-scientists in order to help solve diseases. We harness the diversity of New York`s institutions and people to drive scientific discoveries that will vastly improve clinical care — ethically, equitably and urgently. We advocate and educate, sharing our findings with the global scientific, medical and thought leadership communities to broaden the reach of the New York Genome Center to help patients in every corner of the world. We create synergies through collaboration to continually innovate and advance our vision.